Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma.

@article{Paramita2009TwostepEV,
  title={Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma.},
  author={Dewi Kartikawati Paramita and Jajah Fachiroh and Sofia Mubarika Haryana and Jaap M Middeldorp},
  journal={Clinical and vaccine immunology : CVI},
  year={2009},
  volume={16 5},
  pages={706-11}
}
Undifferentiated nasopharyngeal carcinoma (NPC; WHO type III) is 100% associated with Epstein-Barr virus (EBV) infection and the fourth most prevalent cancer in Indonesian males. Therapy failure is high, since most patients come to the hospital at an advanced stage of disease. Screening for early-stage NPC is needed. Here, a simple and economical two-step… CONTINUE READING